180 Life Sciences EV/EBIT
Quel est le EV/EBIT de 180 Life Sciences?
Le EV/EBIT de 180 Life Sciences Corp. est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à 180 Life Sciences
Que fait 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Entreprises avec ev/ebit similaire à 180 Life Sciences
- Asensus Surgical Inc a EV/EBIT de N/A
- Aurelius Minerals a EV/EBIT de N/A
- Pintec Technology Ltd a EV/EBIT de N/A
- Spherix a EV/EBIT de N/A
- DiscovEx Resources a EV/EBIT de N/A
- Superconductor Technologies a EV/EBIT de N/A
- 180 Life Sciences a EV/EBIT de N/A
- Westar Resources a EV/EBIT de N/A
- Chaparral a EV/EBIT de N/A
- Katoro Gold plc a EV/EBIT de N/A
- Synairgen plc a EV/EBIT de N/A
- Graycliff Exploration a EV/EBIT de N/A
- DBV Technologies a EV/EBIT de N/A